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Abstract
Background: Streptococcus suis infections are a serious problem for both humans and pigs worldwide. The emergence and
increasing prevalence of antibiotic-resistant S. suis strains pose significant clinical and societal challenges.
Results: In our study, we sequenced one multi-drug-resistant S. suis strain, R61, and one S. suis strain, A7, which is fully
sensitive to all tested antibiotics. Comparative genomic analysis revealed that the R61 strain is phylogenetically distinct from
other S. suis strains, and the genome of R61 exhibits extreme levels of evolutionary plasticity with high levels of gene gain
and loss. Our results indicate that the multi-drug-resistant strain R61 has evolved three main categories of resistance.
Conclusions: Comparative genomic analysis of S. suis strains with diverse drug-resistant phenotypes provided evidence that
horizontal gene transfer is an important evolutionary force in shaping the genome of multi-drug-resistant strain R61. In this
study, we discovered novel and previously unexamined mutations that are strong candidates for conferring drug resistance.
We believe that these mutations will provide crucial clues for designing new drugs against this pathogen. In addition, our
work provides a clear demonstration that the use of drugs has driven the emergence of the multi-drug-resistant strain R61.
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Introduction
Streptococcus suis is an emerging zoonotic pathogen with a
worldwide distribution. This pathogen causes meningitis, endo-
carditis, septicemia, septic arthritis, pneumonia, and abortion in
pigs [1]. In the swine industry, S. suis is one of the major causes of
bacterial infections, and these infections can cause considerable
economic loss. Human cases are usually described as occupational
infections that result from direct contact with infected pigs or pig
products, but sudden outbreaks have recently been reported [2].
Human deaths have often been caused by meningitis, but many
could be attributed to a novel form of invasive toxic shock
syndrome [3]. Concomitant with the increasing prevalence of S.
suis infections, multi-antimicrobials have been copiously used
against bacterial pathogens. However, resistance to antimicrobials,
including tetracycline, macrolide-lincosamide-streptogramin B
(MLSB) and fluoroquinolones, has been widely reported in S. suis
strains isolated from pigs [4–10]. As resistance becomes more
common, there is a greater need for alternative treatments.
Despite a push for new antibiotic therapies, there has been a
continued decline in the number of newly approved drugs [11].
Therefore, the emergence of antibiotic-resistant strains poses
an intricate problem for both pig production and public health
[12–14].
Antimicrobial susceptibility profiles and the corresponding
resistance determinants of S. suis have been extensively reported.
However, the genome dynamics and molecular basis for the
mechanism of drug resistance of S. Suis are still not well explained
because of a lack of pertinent sequence information. In the past
few years, the development of next-generation massively parallel
sequencing technologies has significantly improved sequencing
throughput while simultaneously reducing costs [15]. Numerous
bacteria have complete genome sequence data available on public
databases. Multiple genome sequences from different strains of a
single species offer comprehensive information for exploring the
relationship between genotypes and phenotypes, further deter-
mining the genetic basis of biological functions and illustrating the
mechanisms of evolution. To investigate the associations between
drug-resistance mechanism and genetic components diversity of S.
suis, we sequenced two S. suis strains R61 (from the lung of a
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24988diseased pig) and A7 (from the brain of a diseased pig). Of the
currently sequenced S. suis isolates, strain R61 is resistant to most
antibiotics, whereas strain A7 is fully sensitive to all tested
antibiotics. Determining differences in genes’ components between
the high and low drug-resistant strains would enable us to
understand the pattern of drug-resistant gene movement between
organisms and the mechanisms of drug-resistance. R61 and A7
genomes were analyzed in comparison with the complete genome
sequences of S. suis strains P1/7, SC84, and BM407. This
comparative genomic analysis allowed us to characterize this
pathogenic S. suis strain on a global genomic scale.
Results and Discussion
Antimicrobial susceptibility profiles
The results of minimum inhibitory concentration (MIC) testing
indicated that R61 and A7 isolates have almost completely
different antimicrobial susceptibility profiles. S. suis strain A7 was
fully susceptible to all 18 antibiotics tested (Table 1). However, S.
suis strain R61 was resistant to 15 antibiotic agents, including
ampicillin, penicillin, cefotaxime, ceftriaxone, cefuroxime, cefa-
clor, azithromycin, erythromycin, tetracycline, chloramphenicol,
clindamycin, levofloxacin, gatifloxacin, amoxicillin with clavula-
nate potassium and trimethoprim. Strain R61 was susceptible to
cefepime, meropenem and vancomycin. Two previous studies
have examined the antimicrobial susceptibility phenotypes of the
S. suis P1/7, SC84 and BM407 [16,17] strains. Antimicrobial
susceptibility profiles of these five strains are listed in Table 2. Of
the 18 antibiotics used in our MIC test, strain SC84 is resistant to
tetracycline, and strain P1/7 is resistant to erythromycin,
azithromycin, tetracycline and chloramphenicol. Strain BM407
is resistant to erythromycin, azithromycin, tetracycline and
chloramphenicol, but it is susceptible to penicillin and cefuroxime
(Table 2).
General features of sequenced genomes
We generated 2.9 billion high-quality base pairs for a 1,247-fold
genome coverage of R61 and 1.4 billion high-quality base pairs for
a 687-fold genome coverage of A7. The total length of the
assembled R61 genome is 2,390,900 bp, made up of 53 contigs.
The N50 contig size is 24,004 bp. The genome of A7 consists of a
single circular chromosome of 2,038,409 bp (Figure S1; accession
number CP002570). No plasmids were detected in the assembly or
by gel electrophoresis experiments using a 1 kb DNA marker,
which were performed to estimate sample purity prior to genome
sequencing. In total, 2,346 coding sequences (CDSs) were
identified in the R61 genome. This is obviously more sequences
than in any other previously sequenced S. suis strain. However, the
rRNA and tRNA cluster copy numbers were both fewer than in
other S. suis strains, which may help explain why the repeats were
masked during scaffold construction. Large-scale repeats are
always difficult in genome assembly, and it is hard to determine
the real copy number of repeat regions before completely
sequencing the genome. Therefore, the rRNA copy number
presented in Table 3 is only the outcome of the scaffold sequences,
not a real reflection of the final complete genome. The copy
number of rRNA clusters in R61 currently remains uncertain. The
number of insert sequence (IS) elements regions identified in R61
is slightly greater than in other S. suis strains. IS elements encode
only the functions involved in their translocation and transposi-
tion, both within and between genomes. IS elements are thought
to be one of the major players in prokaryote genome [18]
plasticity. A greater number of IS elements indicates that the
genome has undergone more structural variations during strain
evolution. To investigate conservation of sequence blocks between
strains R61 and A7, we used the Mummer 3 software package [19]
to map R61 contig sequences to the A7 finished genome (Figure
S2). We determined that there are multi-locus genome variations,
including duplications, inversions and deletions, between the two
genomes.
Predicted amino acid sequences of each strain were compared
with the Antibiotic Resistance Genes Database (ARDB) [20] to
preliminarily scan for drug-resistant genes in these strains. The
results are shown in Table S1. Each strain seems to possess one
bacitracin-resistant gene. The table demonstrates that strains A7
and P1/7 have the weakest drug-resistant phenotype, and R61
shows the strongest drug-resistant profile among the studied S. suis
strains. There were three tet genes and one erm gene detected in
BM407 and only one tet gene in SC84, which is consistent with
previously reported results [16,17].
Antimicrobial resistance patterns
The 18 antibiotics used in our test are conventionally
categorized into several types based on their mechanism of action,
chemical structure, or spectrum of activity. For example,
ampicillin, amoxicillin-clavulanic acid, cefuroxime and cefotaxime
are grouped as b-lactam antibiotics. Levofloxacin and gatifloxacin
are known as quinolones. Erythromycin and azithromycin are
macrolides. Our analysis reveals that R61 resistance to the 15
tested antibiotics tested is mainly derived from 3 classes of action:
alteration in target site, target protection and reduced drug
accumulation.
Pattern 1: Alteration of the target site to give resistance
against b-lactam and quinolone antibiotics
Altering target sites is the main strategy of bacteria for
developing resistance against antibacterial drugs. Currently, b-
lactam antibiotics are the most widely utilized antibiotics owing to
Table 1. MICs of 18 antimicrobial agents for S. suis A7 and R61 isolated from pigs in China (mg/ml).
Strains Antibiotics MIC (mg/ml)
AMP PEN CPE CFT CAX CRM CFR AZI ERY TET CHR CLI LVX GAT MER VAN AUG TSZ
ATCC49619 #0.06 0.25 #0.25 #0.25 #0.25 0.5 1 #0.25 #0.06 #0.5 2 #0.06 0.5 0.12 0.12 #0.12 #0.5/0.25 #0.25/4.75
A7 #0.06 #0.03 #0.25 #0.25 #0.25 #0.25 #0.5 #0.25 #0.06 1 4 #0.06 0.75 0.25 #0.06 0.25 #0.5/0.25 #0.25/4.75
R61 .4 .42 .2 .2 .2 .4 .2 .0.5 .4 .16 .0.5 .32 32 0.12 0.25 .4/2 .2/38
Abbreviations: AMP, ampicillin; PEN, penicillin; CPE, cefepime; CFT, cefotaxime; CAX, ceftriaxone; CRM, cefuroxime; CFR, cefaclor; AZI, azithromycin; ERY, erythromycin;
TET, tetracycline; CHR, chloramphenicol; CLI, clindamycin; LVX, levofloxacin; GAT, gatifloxacin; MER, meropenem; VAN, vancomycin; AUG, Amoxycillin with clavulanate
potassium; TSZ, trimethoprim/sulfamethoxazole;
doi:10.1371/journal.pone.0024988.t001
Resistance Mechanisms in Streptococcus suis R61
PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e24988their comparatively high effectiveness, low cost, ease of delivery
and minimal side effects [21]. Resistance to b-lactam antibiotics
has been widely reported in Streptococcus pneumoniae. In contrast,
knowledge regarding resistance to b-lactam antibiotics in S. suis is
very limited. b-lactam resistance in S. pneumoniae is a consequence
of generating mosaic pbp genes. Such genes encode penicillin-
binding proteins (PBPs) harboring tens of substitutions throughout
the entire protein [22], which causes these genes to lose their
affinity for the antibiotics.
Four PBPs were identified and classified on the basis of their
sequence similarities in R61 and A7. These are pbp2x, pbp2b, pbp1a
and pbp2a. However, the major contributors to S. suis b-lactam
resistance were still unclear. To determine whether the resistance
mechanism in S. suis was the same as in S. pneumoniae, we aligned
the four kinds of PBP sequences from strains R61, A7, P1/7,
BM407 and SC84. The latter four strains are all b-lactam
sensitive. Comparing the sequences demonstrated that the PBP
sequences are highly homologous in the four b-lactam sensitive
strains. However, each of the four PBP genes in R61 genome
harbors multiple substitutions throughout entire sequence. PBP2x,
which is described as the primary PBP target in b-lactam-resistant
S. pneumoniae strains, appears the most percentage of substitutions
among the four PBPs in R61 genome as compared to strain A7.
PBP2x-R61 contains 189 mutations (159 in the soluble region).
Positions of all mutations (as compared to the penicillin-sensitive
A7) are shown in Figure 1B.
To elucidate this resistance mechanism at an atomic level, we
used Modeller software to perform homology modeling of the
three-dimensional structure of PBP2x-R61 (see Figure 1A).
PBP2x-R61 consists of three domains: an N-terminal domain that
folds into an elongated ‘‘sugar tong’’ shape, a central transpep-
tidase domain (residues 265–619), and a C-terminal domain that is
connected via a 26-residue-long flexible loop. The transpeptidase
domain, which is homologous to that of other PBPs, contains three
conserved amino acid motifs that are in close spatial relationships
as part of the active site of the enzyme. These motifs are the
S
339TMK with an active site serine, the S
396SN triad and the
K
548SG box. In the S
339TMK motif, the TRA mutation has been
extensively verified as a key structural determinant for b-lactam
resistance in S. pneumoniae [23]. Although this residue is conserved
in S. suis R61, its neighbor residue has been mutated (MRI).
M441 is adjacent to the catalytic S339 and is buried in a small
cavity shielded from the active site [24]. We hypothesize that this
mutation is somewhat responsible for antibiotic resistance in the
R61 isolate.
Although mutations have occurred throughout the entire PBP2x
structure, there are two main regions in which the mutations are
concentrated: the active site area and the C-terminal domain. The
sequence of the C-terminal/transpeptidase domain linker region
(residues 619–644) displays 42% variability. We identified PBP2x-
R61 residues adjacent to the active site that are potentially less
Table 3. General features of S. suis genome.
Characteristic Description or value for strain
R61 A7 P1/7 SC84 BM407
Source
(Location)
Pig
(China)
Pig
(China)
Pig
(European)
Human
(China)
Human
(Vietnam)
Culture data 2010 2010 2009 2005 2004
Serotype ND 2 1 7 1
Size(bp) ,2,390,900 2,038,409 2,007,491 2,095,898 2,146,229
G+C content (%) 41.2 41.2 41.3 41.1 41.1
No. of CDSs 2346 1974 1908 1985 2040
Coding density (%) 86.2 88.7 85.1 84.8 83.9
Avg. length of CDSs (bp) 850 887 931 933 932
rRNA (16S-23S-5S) 3 4 4 4 4
tRNA 46 56 56 56 56
IS elements 34 25 27 28 32
Reference(s) This study This study [16] [16] [16]
doi:10.1371/journal.pone.0024988.t003
Table 2. Summary of antimicrobial resistance of S. suis
isolates.
Resistance
phenotype R61 A7 P1/7 SC84 BM407
PEN + 22 2 2
AMP + 22 2 ND
AMC + 2 ND ND ND
CXM + 2 ND ND ND
CEC + 2 ND ND ND
CTX + 2 ND 2 ND
CRM + 2 ND 22
LVX + 2 ND 2 ND
GAT + 2 ND ND ND
ERY + 22 2 +
AZI + 2 ND 2 +
TET + 22 ++
CLI + 2 ND ND ND
CHR + 22 2 +
ND, not determined. The plus sign means resistance. Conversely, the minus sign
stands for sensitivity. The antibiotic abbreviations are shown in Table 1. The
information of resistance phenotype of P1/7, SC84 and BM407 comes from
published papers [16,17].
doi:10.1371/journal.pone.0024988.t002
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asterisk below). Generally speaking, mutations of these residues in
the binding site could affect antibiotic affinity. In sum, there are 25
potential residues, of which 5 were mutated (E232K, S394A,
T489S, T491S and A492V). Interestingly, these mutations are all
similar property of side chain.
To further examine drug-resistant mutations, we employed
KaKs_Calculator 2.0 [25] to detect regions of positive selection in
the PBP2x-R61 sequence. The results show that Ka/Ks (amino
acid mutations over synonymous mutations) values in three regions
(residues 325–368,526–538 and 684–694) are much higher than 1,
meaning that these regions are under strong positive selection
pressure imposed by antimicrobials (Figure 1C, 1A). When
mapping these three regions onto the 3D structure of PBP2x-
R61, we found that they are all in loop regions on the surface of
the protein molecule and are adjacent to the drug molecules. Two
regions close to the cefuroxime molecule surround the cleft of the
catalytic active site. Another region under positive selection is
located in the C-terminal domain, which is far away from the
active site. However, it is adjacent to the lower cefuroxime
molecule. Mutations located in these three regions may affect
either enzyme catalysis or dimer stability, or they may reshape the
active site through long-range structural perturbations. Thus, these
mutations are strong candidates for conferring drug resistance.
Figure 1. Comparison of PBP2x-A7 and PBP2x-R61. (A). Structure of PBP2x from drug-resistant strain R61. Yellow spheres represent locations
of mutations (as compared with the PBP2x sequence from the penicillin-sensitive strain A7). Two molecules of cefuroxime are placed in an equivalent
position to that observed in the complex from PDB 1QMF. Three detected positive selection regions are colored in red. The result demonstrates that
the three regions are all located in loops. Two of the three regions are adjacent to the upper cefuroxime molecule and surround the cleft of catalytic
active site. The third positive selection region is far away from the active site and only located in the C-terminal domain. However, this region is very
close to the lower cefuroxime molecule. (B). Sequence alignment of PBP2x-A7 and PBP2x-R61 and secondary structure assignment. Conserved
mutations are represented in blue, and non-conserved changes are shown in red. Secondary structural elements in the PBP2x-R61 structure are
shown as red cylinders (a-helices) and blue rectangles (b-sheets). Sequence motifs relevant for catalysis (SXXK, SXN and KSG) are underlined. The
transpeptidase domain consists of residues 256–619. Residues that are less than 5 A ˚ from the active site are marked with asterisks. Residues in
regions that are under positive selection are shown within orange rectangular boxes. (C). Selection pressure on the PBP2x-R61 sequence. We used a
sliding window of 10 codons (step size 2 codons) along the PBP2x-R61 DNA sequence to expose selective pressures on different regions. In the plot,
although the general trend is below the threshold of 1 (indicated by a dotted line), there are 3 peaks over the threshold, indicating that these regions
(residues 325–368,526–538 and 684–694) are under positive selection. Mutations in these regions appear to provide some fitness advantage to the
bacterial strain.
doi:10.1371/journal.pone.0024988.g001
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mutations act as the primary cause of drug resistance or whether
they contribute to drug resistance via secondary effects. Based on
this analysis, we conclude that the application of drugs is an
important force in driving the evolution of PBP2x-R61, which is
an essential protein in the acquisition of high-level b-lactam
resistance.
In addition to mutations in PBP2x, mutations in PBP2b also
lead to high levels of drug resistance in S. pneumoniae [26]. We
compared PBP2b sequences from R61 and A7 isolates. Mutations
occur in a mosaic pattern, just as in PBP2x-R61. Some mutations
are homologous to those described in S. pneumonia. Full-length
PBP2b-R61 carries 30 mutations. A 3D structure of PBP2b-R61
was modeled using Modeller software (see Figure S3A). PBP2b is
composed of an N-terminal region and a transpeptidase domain.
There are 8 mutations at the N-terminal region of the structure,
and all other mutations are within the transpeptidase domain. The
central b-sheet of the transpeptidase domain is mostly mutation-
free (only one mutation is present). Mutated residues are located
mostly on loops or a-helices.
MIC testing revealed that R61 is quinolone-resistant, while
strain A7 is quinolone-susceptible. In Streptococci, DNA gyrase
(composed of 2 subunits, GyrA and GyrB) and topoisomerase IV
(made up of ParC and ParE) are the primary targets of quinolone
action. A single mutation in the quinolone resistance-determining
region (QRDR) of GyrA or ParC can reduce susceptibility to
fluoroquinolone [27,28]. The predicted amino acid sequences of
GyrA and ParC in all four quinolone-susceptible isolates (i.e.,
strains A7, BM407, P1/7 and SC84) revealed no amino acid
changes in the QRDRs, implying a high degree of conservation in
the two proteins, even among geographically and epidemiologi-
cally unrelated strains (Figure S4). However, both GyrA and ParC
in the quinolone-resistant strain R61 had mutations. Several
critical amino acid positions, which are related to quinolone
resistance in other Streptococci, also had modifications in the
corresponding R61 proteins. Additionally, we found some
previously unknown positions that were mutated in the R61
QRDRs, which may provide further clues for understanding the
resistance mechanisms in this pathogen.
Pattern 2: target protection-resistance to tetracycline
Tetracycline resistance is one of the most common bacterial
antibiotic resistances. To date more than 40 distinct tetracycline-
resistance genes have been described. These genes confer
resistance via the following three mechanisms: ribosomal protec-
tion, tetracycline efflux and modification of the ribosomal target
[29,30]. We screened for the presence of tetracycline-resistance
determinants in R61 and A7 isolates using known tet genes.
However, because of the low degrees of nucleotide conservation
among these known tet genes, it is difficult to identify tet genes in
new strains. Only one CDS (SSUR61_2068) was detected in R61,
and no tet genes were found in A7, which corresponded with their
resistance phenotypes. The best hit for SSUR61_2068 is
YP_594556, named tet(W), with an E-value of 6610
212 and
34.11% identity. The tet(W) gene, which encodes a ribosomal
protection protein, has recently been described in a wide range of
gram-positive and gram-negative bacteria [31]. However, tet(W)-
mediated tetracycline resistance has not been previously reported
in S. suis or in other major streptococcal pathogens, where
common determinants are tet(M) and tet(O) [32]. To further
examine the gene responsible for tetracycline resistance, we
analyzed the domains in the SSUR61_2068 amino acid sequence.
There are three domains in SSUR61_2068: a Tet_M-like domain,
an EFTU_a domain and an EFTU_b domain. Tet_M-like
domains are found in tetracycline-resistance genes that function
through ribosomal protection. Tetracycline binds to ribosomes
and changes the ribosomes’ conformational states, which disrupts
the elongation cycle and stops protein synthesis. Ribosomal
protection proteins, which have Tet_M-like domains, are thought
to interact with the base of the h34 protein within the ribosome,
causing an allosteric disruption of the primary tetracycline binding
site(s) and releasing the tetracycline molecules from the ribosome
[33,34].
Holden et al. described the tet(M), tet(O), and tet(L) genes in
tetracycline-resistant strain BM407 [16]. Tet(M) and tet(O) act in
ribosomal protection, whereas tet(L) works in efflux. Thus, we may
conclude that although the BM407 and R61 both have
tetracycline resistance, they possess different resistance mecha-
nisms against tetracycline.
Pattern 3: reduced drug accumulation-resistance to
macrolides
We screened for the presence of macrolide-resistance determi-
nants in S. suis isolates. Only one CDS (SSUR61_0925) was
detected in R61 as a homolog of the resistance gene mef(E) (E-value
0.0 and identity 96%). No resistance genes were found in strain
A7. Mef(E) is necessary to confer erythromycin and azithromycin
resistance [35]. Amelia et al. found that Mef(E) appeared to efflux
only 14-membered (erythromycin) and 15-membered (azithromy-
cin) macrolides, and clindamycin was not recognized by the
Mef(E) efflux pump [36].
Strain R61 has a clindamycin-resistant phenotype, but the
corresponding resistance genes could not be detected. Several
studies have reported that the erm(B) gene is associated with
clindamycin resistance, in addition to macrolide and streptogram-
in B resistance. The erm(B) gene has been frequently discovered as
the key clindamycin-resistance gene in a large number of S. suis
strains, including strain BM407 [16,37]. To further inspect the
absence of erm genes in the R61 isolate, we mapped the raw
sequencing short reads to all known erm gene sequences. No reads
clustered, suggesting that there is no erm gene in the R61 genome.
The current erm gene sequences could not help us to detect the
R61-resistance gene. This result probably implies that other
unknown clindamycin-resistance determinants are present in R61,
the confirmation of which requires additional investigations.
Genome dynamics in S. suis strains
Because of the possibility of horizontal gene transfer, single-gene
phylogenies might not reflect the evolutionary history of this
species [38,39]. We used a concatenated DNA sequence obtained
by joining 122 single-copy core gene sequences to reconstruct the
phylogenetic relationships of S. suis strains (see Methods). Bayesian
tree revealed that strain R61 is phylogenetically distinct from
S. suis strains for which genome sequences are currently available
(see Figure 2). Moreover, we reconstructed the relationship of all
available S.suis strains using the MLST typing scheme (http://
www.mlst.net/databases/). The results show that the MLST tree
has the consistent topological structure with that of the Bayesian
tree.
Using InParanoid and MultiParanoid software with a cutoff of
50% identity followed by a manual check, CDSs in the five S. suis
strains were grouped into 1471 clusters (Figure 3). There is a set of
751 predicted CDSs in R61 that were not grouped into ortholog
clusters with CDSs from the other four S. suis strains (see Figure
S5). However, a set of 275 CDSs was shared by all strains but R61.
To check for the absence of these CDSs in the R61 genome, we
used Maq software [40] to map raw short reads to each sequence
Resistance Mechanisms in Streptococcus suis R61
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none of these CDSs are present in the R61 genome.
The CDSs present in all strains but not in R61 strain are
considered as strain-lost genes in the R61 strain. Comparative
analysis of five S. suis genomes indicates a remarkable degree of
gene gain and loss in the genome of strain R61. These strain-
specific genes and strain-lost genes in R61 strain both have low
percentages of BLAST hits for functional annotation (32.09% in
strain-specific genes and 44.87% in strain-lost genes). The
functional groups of R61 strain-specific genes are mainly
associated with replication, recombination, cell wall/membrane
biogenesis and transcription. In contrast, the four highest groups of
functional matches for R61 strain-loss genes were identified as
carbohydrate transport, replication, coenzyme transport and
transcription (Figure 4). We hypothesize that genes related to cell
wall/membrane biogenesis and carbohydrate transport might be
responsible for drug resistance. It has been clearly demonstrated
that bacterial genomes can maintain only a finite number of genes
to survive and propagate [41]. Bacterial genomes are prone to
eliminate genes that fail to provide a meaningful function to
counterbalance gene acquisition. As a result, because of contin-
uous gene gain and loss, bacteria are provided with additional
physiological properties that are helpful for exploiting new niches
[42]. Comparative analysis also revealed a set of 118 genes that
were unique to S. suis strain A7, which is apparently higher than
the number found in BM407, SC84 and P1/7 strains. This
notable diversity might be accounted for by different methods of
gene prediction.
To explore the source of these 751 variable genes in the R61
genome, we compared these genes with the NCBI non-redundant
database to determine potential horizontal gene transfers from
divergent species. BLAST results were filtered to include only
different species matches with greater than 30% amino acid
identity, E-values less than 1.0610
25 and greater than 70%
coverage of the query sequence. Less than half (321/751) of these
CDSs had significant BLAST hits (see Table S2). Of the 321 CDSs
with hits, a set of 139 CDSs encodes hypothetical proteins, which
currently prevents us from a detailed understanding of the
significance of these genes. The majority (205/321) of the
significant BLAST hits match genomes within Streptococcus,
suggesting that horizontal gene transfer among closely related
species is more frequent than among distant species. Our analysis
demonstrates that horizontal gene transfer occurs extensively.
More than 20 genera have occurred gene transfers with strain
R61. Among the horizontally acquired genes, there are 7 nus genes
(arranging into one gene cluster), which were identified as coming
from S. uberis [58]. The nus genes cluster was demonstrated to be
involved in lantibiotic biosynthesis and regulation in S. uberis [43].
Lantibiotics are small antimicrobial peptides that inhibit the
growth of a wide range of other gram-positive bacteria. Moreover,
lantibiotics are nontoxic to humans and are commonly used as a
food preservative [44]. To our knowledge, this is the first report of
the existence of the nus gene cluster in S. suis species.
There are 4 genes identified as drug-resistant genes in the
horizontally acquired genes: SSUR61_0925, SSUR61_1068,
SSUR61_1983 and SSUR61_2113. SSUR61_0925 was men-
tioned above as a mef(E) gene that confers erythromycin and
azithromycin resistance. SSUR61_1068 was a candidate gene
responsible for resistance against amikacin, dibekacin, isepamicin,
netilmicin, sisomicin and tobramycin. SSUR61_2113 is supposed
to be involved in resistance to streptomycin A in strain R61.
SSUR61_1983 is a gene encoding b-lactamase_B, which can
Figure 2. Phylogenetic relationships of S. suis strains. A Bayesian phylogenetic tree was obtained for the concatenated sequence alignment of
122 single-copy core genes from each genome of the currently available S. suis strains. S. pneumoniae TIGR4 and R6 were included as out-groups. The
numbers at the branches are posterior probabilities indicating the support for the branch. The bar indicates the number of substitutions per site (1
per 100 sites).
doi:10.1371/journal.pone.0024988.g002
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b-lactamase is the most common mechanism of resistance to
b-lactam antibiotics in Enterococcus species. However, no Streptococ-
cus species has yet been described as producing b-lactamase when
tested by the chromogenic cephalosporin method [45]. Moreover,
genes encoding b-lactamase were also detected in the genome of
b-lactam-sensitive strain A7. Clearly, this is not the mechanism of
resistance against b-lactam in R61. Thus, our results provide
evidence that strain R61 has developed multi-drug-resistance
patterns through acquisition of sequences from many divergent
lineages.
Materials and Methods
Bacterial strains and antimicrobial susceptibility testing
S. suis strain R61 was isolated from the lung of a diseased pig in
Jiangsu province, China, in 2008, and S. suis strain A7 was isolated
from the brain of a diseased pig in Hubei province, China, in
2007. Antimicrobial susceptibility testing was performed by
assessing the MIC for all isolates using E-test (AB Biodisk,
Sweden) according to the manufacturer’s recommendations.
Streptococcus pneumoniae ATCC49619 was used as a control for all
antimicrobial susceptibility testing.
Genome sequencing and assembly
We used a whole-genome shotgun sequencing strategy with
Illumina Genome Analyzer sequencing technology. A paired-end
sequencing library was constructed with insert sizes of approxi-
mately 500 base pairs (bp). We assembled the short reads using
SOAPdenovo (http://soap.genomics.org.cn/soapdenovo.html). The
de Bruijn graph algorithm used in the software is sensitive to
sequencing errors, so we filtered low-quality reads and used only
high-quality reads for de novo assembly. To fill the intra-scaffold
gaps, we used paired-end information to retrieve read pairs that had
one read that was aligned to the contigs and another read that was
located in the gap region. With this information, we did a local
assembly for the collected reads. Then, these scaffolds were ordered
relative to the genome of S. suis strain 05ZYH33 (deposited in the
NCBI database; GenBank accession number CP000407) using a
combination of the MUMmer 3 [46] and BLAST [47] programs,
and an independent assembly was constructed with Phred/Phrap/
Consed software [48–50]. Gaps between any remaining internal
scaffolds were closed by PCR and edited with Consed. Potential
misassemblies were corrected with PCR amplification and long-read
sequencing.
Sequences and annotations of the Streptococcus suis strains R61
and A7 genomes were deposited in the NCBI database under
accession numbers AEYY01000000 and CP002570, respectively.
Genome annotation and ortholog analysis
Initial open reading frames (ORFs) predictions were performed
using Glimmer3 [51] and Genemarks.hmm [52]. The two
predictions were amalgamated. All known protein sequences from
other S. suis strains (determined from NCBI databases) were
compared to our entire DNA sequences using TBLASTN to
identify any previously missed coding sequences. All putative
ORFs were translated into their respective amino acid sequences
and subjected to BLASTP with a set expected score of 1610
26,i n
the non-redundant protein database (nr, downloaded from NCBI
on October 5, 2010). Those ORFs without BLAST hits against
any other protein were automatically annotated as ‘‘hypothetical
proteins’’. ORFs were grouped into homologous clusters using
InParanoid4 [53,54] and MultiParanoid [55] with the default
parameters. InParanoid4 utilizes pairwise similarity scores, which
are calculated using BLAST, to construct orthology groups
between two species. MultiParanoid applies a clustering algorithm
to merge multiple pairwise ortholog groups from InParanoid into
multi-species ortholog clusters. Each cluster was manually
inspected, and paralogs were kept out. tRNAs and rRNAs were
identified using tRNAscan-SE [56] and RNAmmer1.2 [57],
respectively. IS elements were identified using ISFinder [58].
Phylogenetic analysis
To gain a better understanding of genome evolution in S. suis
strains, six additional completely sequenced S. suis genome
sequences were obtained from NCBI (http://www.ncbi.nlm.nih.
gov). Additionally, we selected two closely related S. pneumoniae
genomes to serve as outgroups. We used 122 single-copy core
genes with nearly identical length and exactly one member in each
of the compared strains for phylogenetic analysis. Sequence
alignments of these genes were concatenated into a large
alignment of 102,365 nucleotides. A phylogenetic tree was
reconstructed using MrBayes 3 [59,60] (200,000 generations
sampled every 100 generations with a gamma distribution model
and invariant class).
Identification of antibiotic-resistance determinants
Antibiotic-resistance genes were identified and characterized
mainly by the following strategies: the amino acid sequence of
each gene was compared with the ARDB with an expected score
cutoff of 1610
25. Matches were screened such that only hits with
35% or greater identity were accepted as candidate resistance
genes. To further explore resistance mechanisms from a structural
Figure 3. Venn diagram showing the distribution of shared
orthologs and strain-special genes between and among S. suis
strains. Comparative analysis of S. suis R61, S. suis A7, S. suis P/7, S. suis
BM407 and S. suis SC84 strains revealed that there were 1,472 gene
clusters that were shared among all five strains. In the case of R61, 1,646
genes of the total 2,346 protein-coding genes aligned in 1,611 clusters.
Comparison of the five strains revealed 751 genes that were unique to
S. suis R61. There were 275 gene clusters that were present in the four
other strains but not in R61. Analysis was done using a total of 10,262
genes from the five S. suis strains. The Venn diagram was created with
web tools provided by the Bioinformatics and Systems Biology Institute
of Gent (http://bioinformatics.psb.ugent.be/webtools/Venn/).
doi:10.1371/journal.pone.0024988.g003
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three-dimensional protein structures with the structures of
antibiotic-resistance proteins. This software can implement
comparative protein structure modeling with known related
structures by satisfying spatial restraints. The unstable conforma-
tion of loop regions was further optimized by the loop model class
in Modeller.
We employed the software KaKs_Calculator 2.0 to detect the
positive selection regions, which is a toolbox that calculates
nonsynonymous (Ka) and synonymous (Ks) substitution rates of
two compared DNA sequences by means of various models. In our
study, the input file is aligned DNA sequences of PBP2x-R61 and
PBP2x-A7. We used a sliding window of 30 bp (step size 6 bp)
along the PBP2x-R61 DNA sequence to calculate the Ka/Ks
value of each 30 bp region by YN model. The value indicates
selective pressures on different regions.
Horizontal gene transfer
Genes present in only one strain were considered strain-specific
genes. In our study, if InParanoid4 did not group the predicted
amino acid sequence of a gene into a homologous cluster with
protein sequences from any other studied strains, the gene was
considered a strain-specific gene. Strain-specific genes from each
species were compared with the NCBI non-redundant database
using BLASTP with the expected value cutoff set at 1.0610
25 to
identify homologs in other species. Matches were screened such that
only hits with 30% or greater identity and 70% or greater coverage
were accepted as potential sources of horizontal gene transfer.
Supporting Information
Figure S1 Schematic circular diagram of the S. suis A7
genome. The circles represent from the outside: circle 1, DNA
base position (kb); circle 2, protein-coding regions transcribed
clockwise; circle 3, protein-coding regions transcribed anticlock-
wise; circle 4, protein-coding regions coloured according to their
functional classification into the Clusters of Orthologous Groups of
proteins; circle 5, tRNA, rRNA and miscellaneous RNA; circle 6,
G/C skew plotted using a 2-kb window and a 0.2-kb sliding step;
circle 7, G+C content plotted using a 2-kb window and a 0.2-kb
sliding step.
(TIF)
Figure S2 Synteny between the chromosome of S. suis
A7 and the assembled contigs of S. suis R61. The X-Y plot
is composed of dots forming syntenic regions between both
genomes. The dots represent predicted S. suis R61 proteins having
an orthologue in the genome of S. suis A7 with co-ordinates
corresponding to the position of the respective coding region in S.
suis A7 genome sequence and indicated in MB. Red dots mean
positive corresponding, whereas blue dots indicate opposite
corresponding.
(TIF)
Figure S3 Comparison of PBP2b-R61 and PBP2b-A7;
structure of PBP2b from drug-resistant strain R61. The
enzyme is composed of two parts: N-terminal region and the
transpeptidase domain. Yellow spheres represent locations of
mutations. It is of note that the central b-sheet of transpeptidase
Figure 4. Comparison of COG functional categories between R61 strain-special genes and R61 strain-loss genes. Each colored
segment indicates the relative contribution of a functional category as a percentage of total COGs. The color of each COG family is indicated in the
figure. (A), COG functional categories of R61 strain-special genes. (B), COG functional categories of R61 strain-loss genes.
doi:10.1371/journal.pone.0024988.g004
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Mutated residues are located mostly on loops or a-helices.
(TIF)
Figure S4 Comparison of PBP2b-R61 and PBP2b-A7;
sequence alignment and secondary structure assign-
ment. Sequence alignment of PPB2b from strain A7 and strain
R61. Conserved mutations are represented in blue, while non-
conserved changes are shown in red. Secondary structural
elements referring to the R61 PBP2b structure are shown as red
cylinders (a-helices), blue rectangles(b-sheets).
(TIF)
Figure S5 Amino acid sequence alignment of the
quinolone resistance-determining regions (QRDRs) of
GyrA and ParC in S. suis strains. Except R61, all strains are
drug-susceptible. Amino acids critical for quinolone resistance are
marked with an arrowhead. Three mutations exist in QRDR of
GyrA-R61, with two critical. Only one of the two critical amino
acids mutates in QRDR of ParC-R61.
(TIF)
Figure S6 Strain-special genes and horizontally ac-
quired genes in the S. suis R61 genome. We concatenated
53 assembled contigs into large nucleotides to draw the circular
diagram of R61 genome. The whole length of the concatenated
nucleotides is 2,390,900 bp. The total length of strain-special
genes is 486,281 bp (accounting for ,20% of the assembled R61
genome). The circles represent from the outside: circle 1, DNA
base position (kb); circle 2, strain-special genes transcribed
clockwise; circle 3, strain-special genes transcribed anticlockwise;
circle 4, horizontally acquired genes.
(TIF)
Table S1 Antibiotic resistance determinants detected in
S. suis strains by searching ARDB. (http://ardb.cbcb.umd.
edu/index.html).
(DOC)
Table S2 Complete list horizontally acquired genes in
R61.
(XLSX)
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